Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Etsuko Kumagai is active.

Publication


Featured researches published by Etsuko Kumagai.


Leukemia Research | 1986

Chromosomal abnormalities in a patient with smoldering adult T-cell leukemia: evidence for a multistep pathogenesis

Isao Sanada; Kiyonobu Nakada; Soei Furugen; Etsuko Kumagai; Kazunari Yamaguchi; Mitsuaki Yoshida; Kiyoshi Takatsuki

A cytogenetic study was performed on peripheral blood cells from a patient with smoldering adult T-cell leukemia (ATL). Four types of primary abnormal clones were found upon examination of a large number of karyotypically analysed cells cultured with and without phytohemagglutinin (PHA). However, human T-cell leukemia virus (HTLV) proviral DNA was confirmed to be monoclonal. This discrepancy can be explained by the hypothesis that these four primary abnormal clones were all derived from a leukemic clone with a normal karyotype and the same integration site of HTLV proviral DNA.


Acta Haematologica | 1988

Clinical study on the serum levels of immunosuppressive acidic protein in patients with adult T-cell leukemia.

Etsuko Kumagai; Takashi Kumagai; Shozo Tanoue; Norio Asou; Kazunari Yamaguchi; Hiroaki Okabe; Mitsuaki Yoshida; Kiyoshi Takatsuki

Serum levels of immunosuppressive acidic protein (IAP) were measured in patients with adult T-cell leukemia (ATL) in order to clarify its significance in this disease. The mean levels in patients with both acute (854 +/- 404 micrograms/ml) and chronic ATL (439 +/- 103 micrograms/ml) were significantly higher than in sera of healthy controls (367 +/- 104 micrograms/ml). However, mean levels in patients with smoldering ATL, healthy T-cell lymphotropic virus type 1 (HTLV-1) carriers and healthy controls showed no differences. Levels in crisis in chronic and smoldering ATL were similar to those in patients with acute ATL. Serial measurements of serum IAP in a number of patients revealed that the levels reflected each patients clinical course, suggesting a potential for use in evaluating the effects of chemotherapy.


AMB Express | 2011

Sensitivity to electrical stimulation of human immunodeficiency virus type 1 and MAGIC-5 cells

Etsuko Kumagai; Masato Tominaga; Shinji Harada

To determine the sensitivities to low electrical potential of human immunodeficiency virus type 1 (HIV-1) and its target cells, HIV-1 and MAGIC-5 cells were directly stimulated with a constant direct current potential of 1.0 V (vs. Ag/AgCl). HIV-1 was incubated for 3 h at 37°C on a poly-L-lysine-coated indium-tin oxide electrode, and then stimulated by an electrical potential. MAGIC-5 cells were seeded onto the electrically stimulated HIV-1 and cultured for 3 days at 37°C. HIV-1-infected cells were measured by multinuclear activation via a galactosidase indicator assay. MAGIC-5 cells were also stimulated by an electrical potential of 1.0 V; cell damage, proliferation and apoptosis were evaluated by trypan blue staining, cell counting and in situ apoptosis detection, respectively. HIV-1 was found to be damaged to a greater extent by electrical stimulation than the cells. In particular, after application of a 1.0-V potential for 3 min, HIV-1LAI and HIV-1KMT infection were inhibited by about 90%, but changes in cell damage, proliferation and apoptosis were virtually undetectable. These results suggested that HIV-1 is significantly more susceptible to low electrical potential than cells. This finding could form the basis of a novel therapeutic strategy against HIV-1 infection.


Journal of Radiation Research | 1990

Effects of long-term radiation exposure on chromosomal aberrations in radiological technologists.

Etsuko Kumagai; Ryuji Tanaka; Takashi Kumagai; Mitsukazu Onomichi; Shozo Sawada


Hematological Oncology | 2006

Chromosomal abnormalities in non-Hodgkin lymphoma with peripheral T-cell type: effect of HTLV-I infection.

Isao Sanada; Toshinori Ishii; Masao Matsuoka; Etsuko Kumagai; Hiromichi Nishimura; Kazunari Yamaguchi; Kiyoshi Takatsuki


Applied Microbiology and Biotechnology | 2003

Effect of electrical stimulation on HIV-1-infected HeLa cells cultured on an electrode surface

Masato Tominaga; Etsuko Kumagai; Shinji Harada


Applied Microbiology and Biotechnology | 2004

Sensitivity of chronically HIV-1 infected HeLa cells to electrical stimulation

Etsuko Kumagai; Masato Tominaga; Shinji Harada


Journal of Biotechnology | 2007

Frequency change-induced alternative potential waveform dependence of membrane damage to cells cultured on an electrode surface

Masato Tominaga; Shouichiro Nagaishi; Maiko Kirihara; Etsuko Kumagai; Shinji Harada; Isao Taniguchi


Journal of Radiation Research | 1988

Effects of Long-term Low Dose Radiation —Epstein-Barr Virus-Specific Antibodies in Radiological Technologist—

Etsuko Kumagai; Ryuji Tanaka; Takashi Kumagai; Yoshiharu Higashida; Mitsukazu Onomichi; Ikuo Nakamura; Shozo Tanoue; Takato Katsuki; Shozo Sawada


Applied Microbiology and Biotechnology | 2007

Effect of electrical stimulation on human immunodeficiency virus type-1 infectivity

Etsuko Kumagai; Masato Tominaga; Shouichiro Nagaishi; Shinji Harada

Collaboration


Dive into the Etsuko Kumagai's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kazunari Yamaguchi

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge